Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies.

Saved in:
Bibliographic Details
Title: Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies.
Authors: Abhishek A; Academic Rheumatology., Stevenson MD; School of Health and Related Research, University of Sheffield, Sheffield, UK., Nakafero G; Academic Rheumatology., Grainge MJ; Lifespan and Population Health., Evans I; BADBIR, University of Manchester, Manchester, UK., Alabas O; BADBIR, University of Manchester, Manchester, UK., Card T; Lifespan and Population Health., Taal MW; Centre for Kidney Research and Innovation, Translational Medical Sciences, University of Nottingham, Derby, UK., Aithal GP; Nottingham Digestive Diseases Centre, Translational Medical Sciences, University of Nottingham, Nottingham, UK., Fox CP; Centre for Cancer Studies, Translational Medical Sciences, School of Medicine, University of Nottingham, Derby, UK., Mallen CD; Primary Care Centre Versus Arthritis, Keele University, Keele, UK., van der Windt DA; Primary Care Centre Versus Arthritis, Keele University, Keele, UK., Riley RD; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Williams HC; Lifespan and Population Health.
Source: The British journal of dermatology [Br J Dermatol] 2024 Mar 15; Vol. 190 (4), pp. 559-564.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2133
DOI:10.1093/bjd/ljad430